EcoDrugPlus

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSPLAG00000014722
Gene Symbol: RPTOR
3 Cross references
212 Possible Orthologues:

Renin

Ensembl ID : ENSPLAG00000022368
Gene Symbol: REN
3 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSPLAG00000007945
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Rxr-Alpha-A

Ensembl ID : ENSPLAG00000004499
Gene Symbol: LOC106951907
3 Cross references
225 Possible Orthologues:

Retinoic Acid Receptor Rxr-Beta-A-Like

Ensembl ID : ENSPLAG00000020333
Gene Symbol: LOC106962184
3 Cross references
211 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPLAG00000019567
Gene Symbol: RARB
4 Cross references
392 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSPLAG00000013418
Gene Symbol: LOC106938577
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPLAG00000012692
Gene Symbol: RARG
4 Cross references
353 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSPLAG00000018178
Gene Symbol: LOC106938341
3 Cross references
377 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSPLAG00000019942
Gene Symbol: LOC106942340
4 Cross references
221 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSPLAG00000014549
Gene Symbol: LOC106950198
4 Cross references
221 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSPLAG00000017727
Gene Symbol: RPL10
3 Cross references
407 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).